Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Letrozole in Metastatic Breast Cancer
NCT00549822Phase 2Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2007
- Primary completion
- May 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Massachusetts General Hospital. Started Oct 2007; status: terminated.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00549822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549822.